Table 2 The analysis between human herpesvirus 8 (HHV-8) positivity and age group, human papillomavirus infection (HPV), and HPV genotypes in three studied groups
Studies groups | ||||
|---|---|---|---|---|
Normal N (%) | Premalignant N (%) | Malignant N (%) | ||
HPV infection | ||||
HPV positive | 24 (92.3) | 19 (86.3) | 14 (100) | |
HPV Negative | 2 (7.7) | 3 (13.7) | 0 (0.0) | 0.34 |
Total | 26 (100) | 22 (100) | 14 (100) | |
HPV genotypes | ||||
HPV 16/18 | 5 (20.8) | 3 (15.8) | 11 (78.6) | |
High-risk HPVs (non-16/18) | 19 (79.2) | 16 (84.2) | 3 (21.4) | 0.0001 |
Total | 24 (100) | 19 (100) | 14 (100) | |
Age groups (yr.) | ||||
> 40 | 18 (69.2) | 12 (54.5) | 3 (21.4) | |
< 40 | 8 (30.8) | 10 (45.5) | 11 (78.6) | 0.015 |
Total | 26 (100) | 22 (100) | 14 (100) | |